This country profile provides an overview of Zimbabwe’s progress in reaching those in need of mass NTD treatment based on 2019 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Treatment coverage

Elephantiasis
0%
Blinding trachoma
36%
Intestinal worms
0%
Bilharzia
0%
River blindness
N/A
1.29 million people received treatment in Zimbabwe in 2019 9.37 million people did not receive treatment in Zimbabwe in 2019

Elephantiasis

Treatment coverage remained at 0% in 2018 and 2019.

People needing treatment
7.68m
People receiving treatment
Zero

Blinding trachoma

Treatment coverage increased from 23% in 2018 to 36% in 2019.

People needing treatment
3.62m
People receiving treatment
1.29m

Intestinal worms

Treatment coverage remained at 0% in 2018 and 2019.

Pre-sch and school-aged children needing treatment
5.85m
Pre-school and school-aged children receiving treatment
No data

Bilharzia

Treatment coverage remained at 0% in 2018 and 2019.

School-aged children needing treatment
2.47m
School-aged children receiving treatment
Zero

River blindness

Zimbabwe does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Zimbabwe.